VTR
55
8
PFG
50
-2
FMC
37
-2
PPL
59
5
DUK
64
7
PSA
63
2
NKE
39
-3
CMS
64
4
WDC
63
13
CVS
52
-6
GM
65
-7
AZO
53
3
MMM
42
5
TSCO
48
-3
ORLY
66
4
WAT
64
7
GOOG
57
2
COP
47
2
LYB
41
-2
AAL
51
-3
VTR
55
8
PFG
50
-2
FMC
37
-2
PPL
59
5
DUK
64
7
PSA
63
2
NKE
39
-3
CMS
64
4
WDC
63
13
CVS
52
-6
GM
65
-7
AZO
53
3
MMM
42
5
TSCO
48
-3
ORLY
66
4
WAT
64
7
GOOG
57
2
COP
47
2
LYB
41
-2
AAL
51
-3
Financhill
Back

Adamas One Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
15

JEWL
Adamas One

Last Price:
0.04
Seasonality Move:
9.8%
Buy
60

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
15
Adamas One (JEWL) is a Sell

Is Adamas One a Buy, Sell or Hold?

  • The current Adamas One [JEWL] share price is $0.04. The Score for JEWL is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • JEWL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JEWL Stock Price Chart

What is Adamas One's stock price today?

  • The Adamas One share price today is $0.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JEWL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $137.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

JEWL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 34.43 Sell
Chaikin Money Flow: 113386 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.05 - 0.13) Sell
Bollinger Bands (100): (0.08 - 0.38) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 69.97 Buy
Chaikin Money Flow: 2429824 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.69) Buy
Bollinger Bands (100): (119.21 - 142.01) Buy

JEWL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.04 Sell
20-day SMA: 0.07 Sell
50-day SMA: 0.1 Sell
200-day SMA: 0.3 Sell
8-day EMA: 0.04 Sell
20-day EMA: 0.07 Sell
50-day EMA: 0.12 Sell
200-day EMA: 0.32 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.25 Buy
20-day SMA: 117.78 Buy
50-day SMA: 122.17 Buy
200-day SMA: 130.04 Buy
8-day EMA: 121.1 Buy
20-day EMA: 119.12 Buy
50-day EMA: 122.54 Buy
200-day EMA: 126.1 Buy

Adamas One Earnings Growth & JEWL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Adamas One Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):